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INTRODUCTION
Obesity, a condition characterized by hyperinsulinemia and
insulin resistance, causes a whole spectrum of subsequent
health problems (1, 2). Obese subjects suffer from an incre-
ased mortality and morbidity risk due to cardiovascular com-
plications (3).
The cause of this increased cardiac risk may be the alterna-
tions in autonomic function. The relationship between sym-
pathetic nervous system activity and obesity has long been
studied. Human studies examining adrenergic activity in
obesity have given conflicting results (4-6). However, a dec-
rease in parasympathetic activity has consistently been report-
ed in obesity (1).
Intact autonomic cardiac control appears to be an impor-
tant protective factor in the pathophysiology of malignant
arrhythmias and sudden cardiac death (7). Previous studies
have shown that obese subjects are more prone to malignant
arrhythmias than non-obese subjects. Therefore, obesity is a
strong predictor of sudden death (3). Several investigators
have reported that reduced heart rate variability (HRV) in
obese subjects, a strong indicator for autonomic disturbances
that may be involved in the mechanism promoting arrhyth-
mias and sudden death in obese subjects (8, 9).
Heart rate turbulence (HRT) was recently introduced as an
indicator for the physiologic changes in the sinus cycle that
follow the occurrence of ventricular premature beat (VPB)
(10). HRT impairment reflects cardiac autonomic dysfunc-
tion, in particular, impaired baroreflex sensitivity (BRS) and
reduced parasympathetic activity (11). HRT can be used as
a non-invasive measure of cardiac autonomic dysfunction (12).
According to the European Society of Cardiology, HRT is
an indicator of vagal activity and an independent predictor
of total mortality after myocardial infarction (13). It has been
shown that there is a relationship between HRT parameters
and cardiovascular outcomes. 
In obesity, autonomic control on cardiac function involve-
ment is controversial. Therefore, the aim of the present study
was to evaluate the cardiac autonomic function in obesity
by the HRT method.
MATERIALS AND METHODS
Study population
Ninety consecutive obese patients who applied to the
Internal Medicine and Cardiology Departments of Afyon
Kocatepe University, School of Medicine Hospital due to
various nonspecific complaints and obesity were included in
this study. The subjects with unstable angina, myocardial
infarction, heart failure, hypertension, diabetes mellitus, val-
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Cardiac Autonomic Function Evaluated by the Heart Rate Turbulence
Method was not Changed in Obese Patients without Co-morbidities
Obese subjects are more prone to sudden deaths and arrhythmias than non-obese
subjects. Heart rate turbulence (HRT) impairment reflects cardiac autonomic dys-
function, in particular impaired baroreflex sensitivity and reduced parasympathetic
activity. Our aim was to evaluate the cardiac autonomic function in obesity by the
HRT method. Ninety obese subjects and 112 healthy subjects were included in
the study. Twenty-four hours ambulatory electrocardiograms were recorded and
Holter recordings were analyzed. HRT parameters, turbulence onset (TO) and tur-
bulence slope (TS), were calculated with HRT View Version 0.60-0.1 software pro-
gram. HRT were calculated in 43 obese and 43 control subjects who had at least
one ventricular premature beat in their Holter recordings. We excluded 47 obese
patients and 69 control subjects who showed no ventricular premature beats in their
Holter recordings from the statistical analysis. There were no significant differences
in TO and TS between obese and control subjects (TO obese: -1.6± ±2.2%, TO
control: -2.1± ±2.6%, p>0.05; TS obese: 8.2± ±5.2, TS control: 10.1± ±6.7, p>0.05,
respectively). HRT parameters seem to be normal in obese patients without co-
morbidities.
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vular heart disease, non-sinus rhythm, hyperthyroidism, left
ventricular hypertrophy, electrolyte disturbances or other
systemic disorders (e.g. chronic renal failure and hepatic fail-
ure) were excluded as well as those who were smokers or on
cardioactive drug medication (especially beta blockers and/
or antiarrhythmic drugs). The obesity was defined as a body
mass index (BMI) ≥30 kg/m2 (BMI was calculated as the
weight in kilograms divided by the square of the height in
meters) (14). Approximately in half of patients, BMI was
between 30 and 34.9 kg/m2. In the remaining patients, BMI
was between 35 and 39.9 kg/m2. The control group consist-
ed of 112 age-matched healthy volunteers. In both groups,
anamnesis and physical examination, routine biochemical
and hematological tests including fasting blood glucose,
blood urea nitrogen, lipids, serum electrolytes, thyroid hor-
mones and hemoglobin, resting 12-lead electrocardiogram
(ECG), transthoracic echocardiography, and treadmill exer-
cise test were performed. According to the ATP III criteria
of metabolic syndrome, there was no subject with metabolic
syndrome in obese patients.
Signed written consent was obtained from all subjects before
their participation in the study, which was approved by the
local ethics committee of our institution.
HRT analyses
All participants (90 obese and 112 control subjects) under-
went 24-hr Holter ECG. Holter recordings were analyzed
with Reynolds Medical Pathfinder Software Version V8.255
(Reynolds Medical, Hedford, England). Firstly, while deter-
mining HRT, abnormal beats and areas of artifact that were
accepted as VPB by computer were excluded, if they are not
manually identified so. In order to calculate HRT, there must
be at least one proper VPB in the entire Holter recording.
Measurements of HRT were done by the original method
(10). Turbulence onset (TO), which is a measure of the early
sinus acceleration after a VPB, is expressed as percentage and
is calculated with the following formula: [(RR1+RR2)-(RR-2+
RR-1)]/(RR-2+RR-1)×100, where RR1 and RR2 are the first
and second sinus RR intervals after the VPB, respectively,
and RR-1 and RR-2 are the first and the second sinus RR inter-
vals preceding the VPB, respectively. Turbulence slope (TS),
which is a measure of the late sinus deceleration after a VPB,
is obtained as the maximal positive slope among all slopes
of a series of regression lines obtained from all sequences of
5 consecutive RR intervals included between the first and
the 20th RR interval following the VPB, and expressed as
ms/RR. TO was calculated for all VPB’s separately and then
averaged, whereas TS was calculated based on an averaged
local tachogram.
Statistical analysis
All the values are expressed as means±SD. Statistical ana-
lyses were performed with SPSS for Windows version 10.0
(SPSS Inc. Chicago, IL. U.S.A.). Differences between groups
were analyzed by the Student’s unpaired t test and chi-square
test, as appropriate. A p value <0.05 was considered as sta-
tistically significant. 
RESULTS
Since there were no VPB in Holter recordings of 47 obese
patients and 69 control subjects, these subjects were exclud-
ed from the statistical analysis. As a result, HRT parameters
were calculated in 43 obese patients (mean age 45.6±10.2
yr, ranged from 27 to 66 yr, 23 women) and in 43 control
subjects (mean age 44.3±10.6 yr, ranged from 22 to 63 yr,
22 women). The demographic and clinical characteristics of
the two study groups are shown in Table 1. The obese patient
group was homogeneous. 
HRT onset and slope did not differ significantly between
obese subjects and controls (TO obese: -1.6±2.2%, TO con-
trol: -2.1±2.6%, p>0.05; TS obese: 8.2±5.2, TS control:
10.1±6.7, p>0.05, respectively, Fig. 1).
DISCUSSION
Obesity-related cardiovascular complications have been
attributed to chronic stimulation of sympathetic activity, im-
posing a functional overload on the heart and the vasculature
(15). In subjects with uncomplicated obesity, chronic hyper-
insulinemia is associated with persistent baroreflex down-reg-
ulation and postprandial sympathetic dominance. It has been
shown that these changes are reversed by weight loss (9).
The heart is richly innervated by afferent and efferent vagal
and sympathetic fibers and is, thus, susceptible to autonomic
influences (16). So, the changes in efferent autonomic traffic
to the heart play a critical role in the genesis and outcome of
cardiac arrhythmias. Increased sympathetic and decreased
LDL, low-density lipoprotein. Values are means±SD. 
Obese patients
(n=43)
Control 
subjects
(n=43)
p
value
Age (yr) 45.6±10.2 44.3±10.6 >0.05
Gender (Male/Female) 20/23 21/22 >0.05
Body mass index (kg/m
2) 35.6±5.2 23.4±2.2 <0.001
Waist circumference (cm) 105±11 73.1±3.2 <0.001
Heart rate (beats/min) 74±97 6 ±10 >0.05
Systolic blood pressure (mmHg) 121±17 118±21 >0.05
Total cholesterol (mg/dL) 197±39 191±35 >0.05
LDL-cholesterol (mg/dL) 119±32 115±30 >0.05
Triglyceride (mg/dL) 153±79 145±68 >0.05
Table 1. The demographic and clinical characteristics of the two
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vagal tone can interact with all of the electrophysiological
mechanisms underlying arrhythmogenesis. The fact that
changes in efferent autonomic traffic are largely under barore-
ceptor control explains why baroreceptor function is corre-
lated with cardiac arrhythmias (17). HRT, BRS, and HRV
provide different information about cardiac autonomic func-
tion, and they are predictors for mortality in heart diseases
(18). Moreover, the moderate correlation between BRS and
HRV (r=0.63) suggests that the two measures explore dif-
ferent functions of autonomic control (19). 
In obese subjects, autonomic function has been investigated
using HRV. The autonomic dysfunction has been shown in
a few studies in obesity (9, 20). Also, it has been shown that
changes of 10% body weight influences HRV. Some authors
showed that a 10% weight gain significantly decreased HRV,
which was attributable to decreased parasympathetic activi-
ty (20). Arone et al. showed that a 10% weight loss increased
parasympathetic activity and decreased sympathetic activity
in both non-obese and obese subjects (21). However, autono-
mic dysfunction has not been shown in other studies (22, 23). 
HRT is highly correlated with spontaneous BRS, and it
may be used instead of BRS (24). It is proven that HRT also
predicts mortality and sudden cardiac death in various car-
diac diseases, such as after myocardial infarction (10), after
coronary artery by-pass grafting surgery (18), and in chronic
heart failure (25). In addition, HRT predicts alterations of
autonomic cardiac function in diabetes mellitus (26) and hy-
perthyroidism (27). However, the implication of HRT has
not been studied in obesity.
In our study, we found that HRT, which may be used in-
stead of BRS, remains normal in obese subjects. This finding
was not similar with that of Hofmann et al. who found that
BMI and waist/hip ratio were inversely correlated with sym-
pathetic activity and BRS was strongly related to the degree
of obesity (1). In addition, some researchers did not find any
deterioration in cardiac autonomic function in obese subjects
by using HRV (22, 23). In the present study, cardiac auto-
nomic function that was determined by HRT was also found
normal. The negative results here may be due to the fact that
the patient population was different in the present study. The
difference was that the patient population had no co-mor-
bidities. Besides, the fact that those HRT indices may indi-
cate a different aspect of the autonomic nervous system activ-
ity compared with HRV or BRS. Ortak et al. have shown
that in the same patient group after myocardial infarction
the indices of HRV were increased but HRT parameters were
not changed (28).
The main limitation of our study seems to be the small
sample size. Because the small sample size results in low sta-
tistical power for equivalency testing, negative results may
be simply due to chance. However, it should be taken into
account that establishing an obesity group without co-mor-
bidities (e.g. diabetes mellitus, hypertension, cardiovascular
and renal disorders) is difficult. Secondly, we did not make
subgroup analysis in our study according to the obesity grade
because the classification of patients according to BMI would
decrease the sample size in subgroups. In this situation, the
statistical power of these subgroups would decrease, too. 
In conclusion, although obesity is associated with excess
cardiovascular morbidity and mortality, in our study, HRT
parameters, which determine the risk of sudden death, did
not alter in obese patients without co-morbidities. Therefore,
weight gain without co-morbidities may not affect cardiac
autonomic function, and the main reason of cardiac autonom-
ic dysfunction in obesity may be the concomitant disorders.
Simple obesity without metabolic syndrome may not have
significant effects on the autonomic function. Of course, we
need further comprehensive studies in obese patients in this
respect.
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Fig. 1. Turbulence Onset (TO, A) and Turbulence Slope (TS, B) values of the two study groups. CI, confidence interval.
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